KR101188013B1 - 핵산 발현의 개선을 위한 신규한 서열 - Google Patents

핵산 발현의 개선을 위한 신규한 서열 Download PDF

Info

Publication number
KR101188013B1
KR101188013B1 KR1020067027165A KR20067027165A KR101188013B1 KR 101188013 B1 KR101188013 B1 KR 101188013B1 KR 1020067027165 A KR1020067027165 A KR 1020067027165A KR 20067027165 A KR20067027165 A KR 20067027165A KR 101188013 B1 KR101188013 B1 KR 101188013B1
Authority
KR
South Korea
Prior art keywords
nucleic acid
sequence
suppressor
promoter
interest
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067027165A
Other languages
English (en)
Korean (ko)
Other versions
KR20070042122A (ko
Inventor
아리이 피터 오떼
테오도루스 헨드리쿠스 야코부스 콱스
리차르드 게오르그 안토니우스 베르나르두스 세발트
헨리쿠스 요하네스 마리아 반 블록란트
Original Assignee
크로마제닉스 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101188013(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 크로마제닉스 비.브이. filed Critical 크로마제닉스 비.브이.
Publication of KR20070042122A publication Critical patent/KR20070042122A/ko
Application granted granted Critical
Publication of KR101188013B1 publication Critical patent/KR101188013B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020067027165A 2004-07-08 2005-07-07 핵산 발현의 개선을 위한 신규한 서열 Expired - Fee Related KR101188013B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58700704P 2004-07-08 2004-07-08
EP2004051405 2004-07-08
EPPCT/EP2004/051405 2004-07-08
US60/587,007 2004-07-08
PCT/EP2005/053251 WO2006005718A2 (en) 2004-07-08 2005-07-07 Novel sequence for improving expression of nucleic acid

Publications (2)

Publication Number Publication Date
KR20070042122A KR20070042122A (ko) 2007-04-20
KR101188013B1 true KR101188013B1 (ko) 2012-10-08

Family

ID=34971366

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067027165A Expired - Fee Related KR101188013B1 (ko) 2004-07-08 2005-07-07 핵산 발현의 개선을 위한 신규한 서열

Country Status (19)

Country Link
US (1) US7825232B2 (https=)
JP (1) JP4805262B2 (https=)
KR (1) KR101188013B1 (https=)
CN (1) CN1981057B (https=)
AT (1) ATE378426T1 (https=)
AU (1) AU2005261699B2 (https=)
BR (1) BRPI0512798A (https=)
CA (1) CA2573022C (https=)
DE (1) DE602005003369T2 (https=)
DK (1) DK1763586T3 (https=)
EA (1) EA011747B1 (https=)
ES (1) ES2296201T3 (https=)
IL (1) IL180531A (https=)
MX (1) MXPA06014553A (https=)
NO (1) NO341862B1 (https=)
NZ (1) NZ551510A (https=)
PT (1) PT1763586E (https=)
WO (1) WO2006005718A2 (https=)
ZA (1) ZA200610470B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
ES2384391T3 (es) 2004-11-08 2012-07-04 Chromagenics B.V. Selección de células hospedantes que expresan proteína a altos niveles
KR101271884B1 (ko) * 2004-11-08 2013-06-05 크로마제닉스 비.브이. 고수준으로 단백질을 발현하는 숙주세포의 선택
US8999667B2 (en) 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
EP2443239B1 (en) 2009-06-15 2015-11-25 Cellagenics B.V. Novel stringent selectable markers
WO2011159157A1 (en) 2010-06-15 2011-12-22 Cellagenics B.V. Novel intergenic elements for enhancing gene expression
DK2611915T3 (da) 2010-09-01 2015-06-22 Cellagenics B V Nukleinsyrefragmenter fra en ribosomal proteinpromoter til forstærkning af genekspression
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1600510E (pt) * 2001-07-04 2007-06-25 Chromagenics Bv Sequências de adn com actividade anti-repressora.
CA2489475C (en) 2002-06-14 2011-03-29 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
ATE354645T1 (de) * 2002-12-20 2007-03-15 Chromagenics Bv Mittel und methoden zur produktion eines proteins durch chromatin-öffner, die chromatin zugänglicher für transkriptionsfaktoren machen können

Also Published As

Publication number Publication date
AU2005261699B2 (en) 2009-07-23
MXPA06014553A (es) 2007-03-12
HK1097004A1 (en) 2007-06-15
ATE378426T1 (de) 2007-11-15
CA2573022C (en) 2012-03-06
PT1763586E (pt) 2008-02-25
JP2008505626A (ja) 2008-02-28
KR20070042122A (ko) 2007-04-20
BRPI0512798A (pt) 2008-04-08
DE602005003369D1 (de) 2007-12-27
CN1981057A (zh) 2007-06-13
EA011747B1 (ru) 2009-06-30
AU2005261699A1 (en) 2006-01-19
EA200700233A1 (ru) 2007-06-29
CN1981057B (zh) 2012-07-04
NO341862B1 (no) 2018-02-12
US20070212755A1 (en) 2007-09-13
ES2296201T3 (es) 2008-04-16
US7825232B2 (en) 2010-11-02
DK1763586T3 (da) 2008-03-17
CA2573022A1 (en) 2006-01-19
DE602005003369T2 (de) 2009-03-05
IL180531A0 (en) 2007-06-03
WO2006005718A3 (en) 2006-08-17
NZ551510A (en) 2009-10-30
WO2006005718A2 (en) 2006-01-19
IL180531A (en) 2011-04-28
JP4805262B2 (ja) 2011-11-02
NO20070757L (no) 2007-02-08
ZA200610470B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
KR101328300B1 (ko) 고수준으로 단백질을 발현하는 숙주세포의 선택
KR101271884B1 (ko) 고수준으로 단백질을 발현하는 숙주세포의 선택
NZ553700A (en) Selection of host cells expressing protein at high levels using a selectable marker with a non-optimal start codon
KR100942117B1 (ko) 유전자 전사 조절 성질을 포함하는 디엔에이 서열 및 이러한 디엔에이 서열을 탐지하고 이용하는 방법
KR101188013B1 (ko) 핵산 발현의 개선을 위한 신규한 서열
DK2443239T3 (en) New stringent selection markers
Uchida et al. AML1A and AML1B can transactivate the human IL-3 promoter
AU2013213873B2 (en) Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis
RU2749715C2 (ru) Грызуны, характеризующиеся гуманизированным геном tmprss
US9650630B2 (en) Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
KR100951759B1 (ko) 유전자 전사 조절 성질을 포함하는 디엔에이 서열 및이러한 디엔에이 서열을 탐지하고 이용하는 방법
Medina et al. Tissue-specific N-terminal isoforms from overlapping alternate promoters of the human AE2 anion exchanger gene
HK1128490B (en) Selection of host cells expressing protein at high levels
EP2048954B1 (en) An isolated dna fragment of the sparc human promoter and its use
US6635751B1 (en) Isolated nucleic acids encoding activated and suppressive forms of ATF6
US6346606B1 (en) Protein containing a scavenger receptor cysteine rich domain
US20080287361A1 (en) Compositions and methods of using CRMP-1 and its fragments for treating cancer
HK1097004B (en) Novel sequence for improving expression of nucleic acid

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

AMND Amendment
J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20150827

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20160831

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20180903

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20190829

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20220927

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220927